How M.D. was paid
$1.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Other | Total |
|---|---|---|---|---|---|
| Lara Sullivan, M.D.Former President, Chief Executive Officer and Chief Medical Officer | $646,875 | $723,076 | $291,094 | $10,500 | $1,671,545 |
| Jitendra WadhanePrincipal Financial and Accounting Officer | $414,000 | $207,702 | $134,550 | $10,500 | $766,752 |
| Pamela ConnealyFormer Chief Financial Officer and Chief Operating Officer | $262,796 | $402,365 | $349,092 | $410,984 | $1,425,237 |
What changed and why
- $1.7MFormer CEO Lara Sullivan received total compensation of $1,671,545 in fiscal 2025, down significantly from $7,072,943 in 2024.
- 75%The Compensation Committee determined that 75% of applicable corporate objectives were achieved for annual incentive bonuses.
- Dr. Sullivan ceased serving as President, CEO, and CMO effective February 2, 2026, and received severance arrangements.
- Pamela Connealy retired as CFO and COO effective July 1, 2025, receiving severance and accelerated vesting benefits.
- $767KJitendra Wadhane joined as named executive officer with total compensation of $766,752 for fiscal 2025.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.